window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Therapeutic Areas

  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain,Therapeutic Areas

    CellProthera acquires full rights to transendocardial catheter from Celyad Oncology

    CellProthera has acquired full rights to the transendocardial catheter originally [...]

    May 5, 2026
  • Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Oryzon appoints Rolando Gutierrez-Esteinou as chief medical officer for CNS programs

    Oryzon Genomics has appointed Rolando Gutierrez-Esteinou, as chief medical officer [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Nucleome Therapeutics appoints Michelle Morrow as chief scientific officer

    Nucleome Therapeutics has appointed Michelle Morrow as chief scientific officer, [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Hansa Biopharma reports 135% Q4 revenue growth and BLA submission for imlifidase

    Hansa Biopharma has reported a 135% increase in fourth-quarter revenue [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Positive Phase 3 KALOS and LOGOS trial results for Breztri published in The Lancet Respiratory Medicine

    Full results from the Phase 3 KALOS and LOGOS trials [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Hans Schambye appointed as CEO of BOOST Pharma as BT‑101 advances toward Phase 3

    BOOST Pharma has appointed Hans Schambye as its new chief [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research

    SPT Labtech and BellBrook Labs have introduced a miniaturised high-throughput [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    BNPP AM Alts invests $115M in ILiAD Biotechnologies to advance whooping cough vaccine

    BNP Paribas Asset Management Alts (BNPP AM Alts) has made [...]

    May 5, 2026
  • Biotech & Pharma Business,Pharmaceuticals and therapeutics,Therapeutic Areas

    Kainova Therapeutics raises $32m CAD Series B to advance immuno-oncology and inflammation pipeline

    Kainova Therapeutics has secured $32m CAD in a Series B [...]

    May 5, 2026
  • Drug Discovery & Development,Therapeutic Areas

    Circio and University of Texas Medical Branch partner on infectious disease research using circular RNA

    Circio has entered a research collaboration with the University of [...]

    May 5, 2026
Previous91011Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • William Blair highlights Carterra as key player in AI-driven drug discovery shift
    Categories: Digital & Data, Drug Discovery & Development
  • 23andMe study links genetics to GLP-1 weight loss outcomes and side effects
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Genomics and sequencing, Therapeutic Areas
  • Life Biosciences raises $80M to advance gene therapy for optic neuropathies
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top